Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Campbell Soup $2.7 billion acquisition of Sovos Brands
We are advising Campbell Soup on the acquisition
Virgin Orbit chapter 11 plan confirmed
We advised Virgin Investments as DIP lender, prepetition lender and equityholder in connection with the restructuring
Francisco Partners and TPG $6.5 billion acquisition of New Relic
We are advising Francisco Partners and TPG on the acquisition
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction
Upgrade $100 million acquisition of Uplift
We advised Upgrade on the transaction
Chase Corporation $1.3 billion acquisition by KKR
We are advising Chase Corporation on the transaction
Toyota $1.5 billion sustainability bond offering
The investment-grade notes are due 2026, 2028 and 2033
Bridgepoint sale of DMC Power to Golden Gate Capital
We advised Bridgepoint on the transaction
ExxonMobil $4.9 billion acquisition of Denbury
We are advising ExxonMobil on the acquisition
TPG acquisition of Forcepoint G2CI from Francisco Partners
We are advising TPG on the acquisition